Tembec has approximately 3,000 employees and annual sales of approximately CDN$1.5 billion. Tembec is listed on the Toronto Stock Exchange (TMB). More information is available at www.tembec.com. Forward-Looking Statements This …
Investors are a little more bullish on shares of Legg Mason BW Global Income Opp lately if you consider the downtick …
Both poster presentations feature Advaxis’ proprietary Listeria monocytogenes (Lm)-based technology ... ADXS has a 1 …
Legg Mason and its affiliates do not engage in selling shares of the Funds. …
U.S. stock indexes finished with tiny gains Wednesday as retailers jumped after a strong hiring forecast from Target and energy companies rose along with oil prices. On Wednesday: The Standard & Poor's 500 index edged up 1.89 points, …
Advaxis, Inc., launched on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. …
(AP Photo/LM Otero, File) How much the incident will cost Mezger, who has been CEO since 2006, isn't clear. He was paid $9 million last year in salary and stock
"The move to the Legg Mason tower is reflective of where we are going as a …
Medifast’s new Legg Mason Tower office, with its 17th and 18th floor views ...
But research has shown millennials tend to be wary of the stock market. According to a Legg Mason survey from earlier this year, 85 percent of millennials say …